A unique monoclonal antibody that can help anticancer agents to effectively reach inside a cancer cell and target proteins vital for the survival of the cell has been discovered by American researchers. Scientists from Memorial Sloan-Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers. Unlike ...
View the Original article
